ARK Investment Management’s Senti Biosciences SNTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28
| Closed | -$97 | – | 198 |
|
|
2024
Q4 | $97 | Sell |
28
-176,638
| -100% | -$612K | ﹤0.01% | 181 |
|
|
2024
Q3 | $399K | Buy |
176,666
+18,089
| +11% | +$40.9K | ﹤0.01% | 166 |
|
|
2024
Q2 | $438K | Sell |
158,577
-4,515
| -3% | -$12.5K | ﹤0.01% | 170 |
|
|
2024
Q1 | $615K | Sell |
163,092
-33,894
| -17% | -$128K | ﹤0.01% | 199 |
|
|
2023
Q4 | $1.3M | Buy |
196,986
+14,378
| +8% | +$94.9K | 0.01% | 195 |
|
|
2023
Q3 | $754K | Sell |
182,608
-374
| -0.2% | -$1.55K | 0.01% | 198 |
|
|
2023
Q2 | $1.15M | Sell |
182,982
-7,165
| -4% | -$44.9K | 0.01% | 195 |
|
|
2023
Q1 | $2.24M | Sell |
190,147
-2,436
| -1% | -$28.7K | 0.02% | 163 |
|
|
2022
Q4 | $2.72M | Sell |
192,583
-16,187
| -8% | -$228K | 0.02% | 148 |
|
|
2022
Q3 | $4.53M | Sell |
208,770
-11,458
| -5% | -$249K | 0.03% | 137 |
|
|
2022
Q2 | $21.9M | Sell |
220,228
-7,620
| -3% | -$757K | 0.13% | 85 |
|
|
2022
Q1 | $22.5M | Sell |
227,848
-8,420
| -4% | -$831K | 0.09% | 105 |
|
|
2021
Q4 | $23.3M | Buy |
236,268
+3,556
| +2% | +$351K | 0.07% | 130 |
|
|
2021
Q3 | $23.1M | Buy |
232,712
+24,061
| +12% | +$2.39M | 0.06% | 136 |
|
|
2021
Q2 | $20.7M | Buy |
+208,651
| New | +$20.7M | 0.04% | 167 |
|